Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
30.88
+0.55 (1.81%)
At close: May 16, 2025, 2:57 PM CST

Shandong Keyuan Pharmaceutical Company Description

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of active pharmaceutical ingredients.

It offers gliclazide, for the treatment of NIDDM; metformin hydrochloride used as an adjunct to diet and exercise in adult patients with NIDDM; isosorbide mononitrate for prevention of angina pectoris and treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction; isosorbide dinitrate to prevent angina pectoris due to coronary artery disease; mecobalamin for peripheral neuropathies; lansoprazole to treat acid-reflux disorders, peptic ulcer disease, h.

pylori eradication, and prevention of gastrointestinal bleeds; ropivacaine hydrochloride for obstetric and regional anesthesia; isoflurane; fluoxetine hydrochloride, an anti-depression drug; clemastine fumarate, an anti-allergic agent; isoprenaline hydrochloride to treat mild or transient episodes of heart block; esmolol hydrochloride for the rapid control of ventricular rate; xanthinol nicotinate to treat of brain function barrier, cerebral embolism and cerebral thrombosis; amlexanox for treatment of aphthous ulcers; nisolsipine for hypertension; clarithromycin lactobionate; trepibutone; propafenone hydrochloride; diclofenac potassium to treat osteoarthritis and rheumatoid arthritis; chlorzoxazone for relief of discomfort associated with acute painful musculoskeletal conditions; esomeprazole sodium treats related gastric ulcer disease and zollinger-ehrlich syndrome; palonosetron hydrochloride, a chemotherapy adjuvant medication; edaravone, a cerebral protective agent; vildagliptin to treat diabetes; etamsylate, a hemostatic medication; pranoprofen that is a non-steroidal anti-inflammatory analgesic and antipyretic drugs; parecoxib sodium; and lurasidone hydrochloride, a medication for schizophrenia.

The company was incorporated in 2004 and is headquartered in Jinan, China.

Shandong Keyuan Pharmaceutical Co., Ltd.
Country China
Founded 2004
Industry Drug Manufacturers - General
Sector Healthcare
Employees 696
CEO Jianwei Wang

Contact Details

Address:
Keyuan Street
Jinan, 251601
China
Phone 86 531 8872 9285
Website keyuanpharm.com

Stock Details

Ticker Symbol 301281
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000061V8
SIC Code 2834

Key Executives

Name Position
Jianwei Wang General Manager